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Adrenomedullary chromaffin cells are catecholamine (CA)-producing cells originating from trunk neural crest (NC) via sympathoadrenal
progenitors (SAPs). We generated NC and SAPs from human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs)
in vitro via BMP2/FGF2 exposure, ascertained by qPCR and immunoexpression of SOX10, ASCL1, TFAP2a, and PHOX2B, and by fluores-
cence-activated cell sorting selection for p75NTR and GD2, and confirmed their trunk-like HOX gene expression. We showed that
continuing BMP4 and curtailing FGF2 in vitro, augmented with corticosteroid mimetic, induced these cells to upregulate the chromaffin
cell-specificmarker PNMTand other CA synthesis and storagemarkers, and we demonstrated noradrenaline and adrenaline by Faglu and
high-performance liquid chromatography. We showed these human cells’ SAP-like property of migration and differentiation into cells
expressing chromaffin cell markers by implanting them into avian embryos in vivo and in chorio-allantoic membrane grafts. These cells
have the potential for investigating differentiation of human chromaffin cells and for modeling diseases involving this cell type.
INTRODUCTION
Adrenal chromaffin cells are neural crest (NC) derivatives
(Le Douarin and Teillet, 1974) and, via sympathoadrenal
progenitors (SAPs), are closely related to sympathetic
neurons (Huber et al., 2009; Shtukmaster et al., 2013).
Both produce catecholamine (CA) biosynthesis enzymes
including tyrosine hydroxylase (TH) and dopamine-b-hy-
droxylase (DbH). The major CA for sympathetic neurons
is noradrenaline since they lack the adrenaline-synthe-
sizing enzyme phenylethanolamine-N-methyltransferase
(PNMT), while chromaffin cells secrete both due to the
presence of PNMT (Levitt et al., 1965). The CA vesicles of
chromaffin cells and the synaptic vesicles of sympathetic
neurons (Huber et al., 2009; Teichberg and Holtzman,
1973) possess chromogranin A, chromogranin B/secretog-
ranin I (CgB/SgI; predominant in human adrenal chro-
maffin cells), and chromogranin C/secretogranin II (CgC/
SgII) (Crivellato et al., 2008; Trifaro, 2002), which have
diverse functions.
In addition to TH, DbH, PNMT, and Cg, a number of
other molecules are markers of NC and SA development.
P75NTR is indicative of early NC, i.e., NC stem/progenitor
cells (NCPCs), as is, in some species, HNK1. There are
several NC (SOX10, TFAP2) and SA transcription factors
(ASCL1, PHOX2B, GATA3, andHAND2). The SA antibodies
and the ganglioside GD2 indicate SAPs and chromaffin
cells and the B2B1 antigen, MYCN, peripherin (PRPH),
and neurofilament (NF) distinguish sympathetic neuron
lineage progression (Anderson et al., 1991; Howard, 2005;
Huber et al., 2009; Lumb and Schwarz, 2015; Mobley
et al., 2015; Shtukmaster et al., 2013; Troy et al., 1990;
Zhu et al., 2012).
Functionally, adrenal chromaffin cells are central to the
‘‘fight or flight’’ response. They also release enkephalin-
related peptides to produce analgesic effects (Jozan et al.,
2007; Livett et al., 1981) and also many growth factors
(Krieglstein et al., 1998; Schober et al., 1998). Pathologi-
cally, chromaffin cells are affected in the pheochromocy-
toma associated with multiple endocrine neoplasia type
2A and 2B (MEN2A and MEN2B) (Wells et al., 2013) and
are also related to neuroblastoma as they both originate
from the SA lineage (Szabo et al., 2012). Clinically, autolo-
gous intra-brain transplantation of chromaffin cells
ameliorated Parkinson’s disease but the beneficial effects
were transient (Drucker-Colin and Verdugo-Diaz, 2004).
Chromaffin cell implants have also been suggested to alle-
viate cancer pain, and phase II clinical trials showed their
feasibility (Lazorthes et al., 2000). However, the availability
only of allogenic donor material limited the wider applica-
tion of this approach (Jozan et al., 2007).
There aremany studies on the production ofNCPCs from
pluripotent cells, and the differentiation of these cells into
autonomic neurons (Lee et al., 2007; Oh et al., 2016). Pro-
duction of SAPs from mouse embryonic stem cells (ESCs)
and selection for GD2 has been demonstrated (Saxena
et al., 2013). Here we describe modifications to these
methods applied to human pluripotent ESCs (hESCs)
and human induced pluripotent stem cells (iPSCs) to pro-
duce human adrenal chromaffin-like cells. A human cell
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resource will provide a platform to study development
and physiology of these cells as well as allowing insight
into the mechanisms of diseases that involve the SA and
adrenal chromaffin cell lineage, such as neuroblastoma
and MEN2A and 2B. In addition, the potential capacity to
produce these cells in large numbers from human autolo-
gous sources may assist in the clinical practices that have
been hampered by the previous unavailability of donor
material and also provide an initiative in regenerative ther-
apies (Soto-Gutierrez et al., 2010).
RESULTS
NCPCs Differentiated from Human Pluripotent Cells
Express SAP, Neuronal, and Chromaffin Markers
We differentiated H9 hESCs into neurectoderm-like caudal
(i.e., caudal to forebrain) neural progenitors (CNPs) by
TGF-b and GSK3b inhibition. This was followed by FGF2
and BMP2 treatment to generate NCPC neurospheres (we
refer to these cells as NCPC-xd, where x is the duration of
FGF2/BMP2 treatment in days) (Denham et al., 2015) (Fig-
ures 1A, S1A, and S1B). To quantitate the efficiency of gen-
eration of NCPCs, we fluorescence-activated cell sorting
(FACS) analyzed dissociated neurospheres using p75NTR
antibody. Most cells (89% ± 5%, N = 5) were p75NTR+
(Figure 1B), and almost all the p75NTR+ cells expressed
another NC marker, HNK1 (Figure 1B). We analyzed the
NCPCs with antibodies to SOX10 and TFAP2a, two NC
transcription factors, and to pro-neuronal marker, ASCL1,
which is expressed by pro-neuronal SAPs but later downre-
gulated, and PRPH, which is expressed in sympathetic
neuroblasts and neurons but not chromaffin cells (Lo
et al., 1991; Troy et al., 1990). The majority of the
SOX10+ cells expressed TFAP2a, and ASCL1 and PRPH
markers were elevated especially in cells with lower
SOX10 levels (Figure 1C).
The duration and level of BMP exposure effects differen-
tiation of SAPs (Huber et al., 2008; Schneider et al., 1999),
and FGF2 induces neuronal differentiation (Carnahan
and Patterson, 1991b). We investigated whether there
would be an effect of prolonging FGF2/BMP2 exposure
(that is NCPC-6d compared with NCPC-4d). qPCR analysis
showed, compared with the starting H9 hESCs, an upre-
gulation of SOX10, and also a modest increase in MYCN
expression, a marker for NC cells, SAPs, and neurons (Mob-
ley et al., 2015; Saxena et al., 2013). The expression of the
pro-neuronal transcription factors, ASCL1, HAND2, and
PHOX2B, and the CA synthesis enzymeswas increased (Fig-
ure 1D). Also increased was SOX2, which is important in
pluripotency and in the neuroectoderm, but is downregu-
lated in early NC then later upregulated (Cimadamore
et al., 2011), while the pluripotency gene OCT4 was sup-
pressed (Figure 1D).
Using theCNP cells as a basis (see Figure 1A), the earlyNC
genes SOX10 andMYCN commenced upregulation quickly
(detectable in NCPC-2d cells). mRNA for the SA specifica-
tion transcription factor GATA3 (Moriguchi et al., 2006)
was also detected in NCPC-2d cells, increased about
9-fold in NCPC-4d, before decreasing slightly in NCPC-6d
cells (Figure 1E). In contrast the increase in the pro-
neuronal geneHAND2 and theCA synthesis enzyme genes,
which reflect later SA differentiation, were only apparent
after 6 days of FGF2/BMP2 treatment (Figure 1E). RET, cod-
ing for the receptor forGDNF, is highly expressed in human
neuroectoderm (Attie-Bitach et al., 1998), is absent in early
NC cells and is re-expressed in the sympathetic primordia
but declines in adrenal chromaffin cells (Allmendinger
et al., 2003; Huber et al., 2002). In the H9 hESC system,
compared with neuroectoderm-like CNPs, RET expression
followed a similar undulating trajectory (Figure 1E).
Increasing aTH, DbH, and PNMT expression by qPCR
analysis is consistent with SA differentiation related to
duration of FGF2/BMP2 exposure (Figures 1D and 1E).
SA1 immunoreactivity marks SAPs, increasing in chro-
maffin cells and decreasing in sympathetic neurons (Car-
nahan and Patterson, 1991a; Lumb and Schwarz, 2015).
FACS showed that almost 80% of p75NTR+ cells of
NCPC-4d were SA1+, declining to 66% 2 days later (Fig-
ure 2B). In contrast, the proportion ofNCPCs co-expressing
the SA marker ganglioside GD2 and the pro-neuronal
marker B2B1 increased from 4 to 6 days (see below). NF
Figure 1. Characterization of Human NCPCs/SAPs
(A) Differentiation protocol of hESCs to NCPC/SAP-like cells and further to chromaffin-like cells. For details, refer to Figure S1.
(B) FACS analysis of NCPC-6d showing co-expression of the NCPC markers p75NTR and HNK1. Representative of ten independent inductions
of H9 cells. Non-specific antibody binding is shown as antibody isotype control.
(C) Immunofluorescence of NCPC-6d cells with the NCPC/SAP markers SOX10, TFAP2a, ASCL1, and PRPH. Note the co-expression of early NC
markers TFAP2 and SOX10 and a trend for markers of lineage progression, ASCL1 and PRPH, to segregate from early NC marker SOX10. Scale
bars, 50 mm.
(D) qPCR analysis of NCPC-4d and NCPC-6d normalized to undifferentiated hESC, showing upregulation of diverse NC/SAP markers.
(E) Time point qPCR analysis NCPC-2d, NCPC-4d, and NCPC-6d normalized to CNP showing NC/SAP markers appear progressively. b2M,
b2-microglobullin (housekeeping gene). N R 3 independent experiments.
Error bars represent mean ± SEM. ns, not significant, *p > 0.05, **p > 0.01, ****p > 0.0001.
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expression was also detected in NCPCs by FACS, using SK-
N-BE(2)C humanneuroblastoma cells and undifferentiated
hESCs as positive and negative controls for SA and sympa-
theticmarker expression (Figure S3). This is consistent with
NCPCs progressing to an SAP state initially, but longer
FGF2/BMP2 favoring neuronal lineages at the expense of
chromaffin properties (Anderson et al., 1991; Carnahan
and Patterson, 1991b; Stemple et al., 1988). Nevertheless,
the NCPC-6d population was still heterogeneous (see Fig-
ures 1C and S2).
NCPCs Have a Trunk NC Identity
Antero-posterior positional information is important in
NC development (Lee et al., 2005; Zhang et al., 2010),
and a major mediator is the HOX gene code (Nelms and
Labosky, 2010). For trunk positional identity consistent
with SAPs, the hESC-derived NCPCs should express
higher-number trunkHOX genes (Huber et al., 2012) rather
than the low-number cranial and vagalHOX genes (Figures
2B and S4). We performed qPCR analysis for HOXB1, A2,
B2, B4, A5, A7, B7, and A10 (Bhatt et al., 2013). Cranial
gene HOXB1 was downregulated relative to CNP and
HOXA2, B2 and B4 were not elevated (Figure 2B). HOXA5
expression, marking the vagal/trunk transition, was upre-
gulated relative to CNP cells by the NCPC/SAP differentia-
tion process but not to the degree seen inNCPCswith vagal
properties (Figures 2B and S4). HOXB7 was upregulated
over 6 days of FGF2/BMP2 treatment relative to CNPs
(Figure 2B), and HOXA10 expression was also increased
especially compared with vagal NCPCs (Figure S4).
Figure 2. Human NCPCs Express SA Markers and Possess the Positional Identity of Trunk NC Cells
(A) FACS analysis of differentiation of H9 NCPC-4d and NCPC-6d (both representative of ten separations) with heightened expression of
NCPC marker p75NTR and SAP marker SA1.
(B) qPCR HOX gene analysis of CNP, NCPC-2d, NCPC-4d, and NCPC-6d. CNP (cranial positional identity, low-number HOX) was used to
normalize the expression except for HOXA10, which was normalized to b2M. NCPC/SAP induction is accompanied by decreased expression
of lowest-number and increased expression of higher-number HOX paralogs. ND, not detectable, pooled from N = 4 different inductions
each, PCRs in triplicate.
Error bars represent mean ± SEM. ns, not significant, *p > 0.05, **p > 0.01, ****p > 0.0001.
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Differentiating hESC-Derived NCPCs to Chromaffin
Cells
Wedeveloped a protocol (Figures 1A and S1B) based on that
used formouse cells (Saxena et al., 2013), and for humanad-
renal chromospheres (Santana et al., 2012), to obtain hu-
man chromaffin-like cells, using markers used by the latter.
We subjected the H9 NCPCs (i.e., cells previously exposed
to FGF2/BMP2) in vitro for 6–9 dayswith 500 pg/mLhuman
recombinant BMP4 (without FGF2), or with dexametha-
sone plus phorbol 12-myristate 13-acetate (PMA) (Dex +
PMA = DP), or both (DPBMP4). This resulted in upregula-
tion of SAP/chromaffin markers aTH and CgB and, most
importantly, chromaffin-restrictedmarker PNMTby immu-
nofluorescence, thus demonstrating the chromaffin differ-
entiation capacity of the hESC-derived NCPCs (Figure 3A).
We investigated the efficiency of differentiating chro-
maffin cells from dissociated NCPC-4d and NCPC-6d cells,
the latter having a longer initial treatment with FGF2, with
both having continuous exposure to BMP2/4. aTH was
highly efficiently induced in all conditions, but DP plus
BMP4 treatment of NCPC-4d cells resulted in a high pro-
portion of cells that were CgB+, but few cells that were
NF+ (i.e., neuronal) (Figure 3B left). However, with NCPC-
6d as the starting point, BMP4 induced more NF+ cells
while CgB+ cells were reduced (Figure 3B right), which is
consistent with elevated pro-neuronal B2B1+ cells at the
NCPC-6d stage (see below). Genes for CA synthesis en-
zymes and NC and SA transcription factors increased
expression (Figure 3D). MYCN favors the differentiation
of sympathetic neurons and acts against differentiation of
chromaffin cells (Mobley et al., 2015; Zhu et al., 2012).
Cells differentiated from NCPC-4d cells under BMP4, DP,
and DPBMP4 all showed less MYCN expression by qPCR
than the starting NCPC-4d SAP cells (Figure 3G). On the
other hand, cells differentiated from NCPC-6d cells under
BMP4-only showed no decrease in MYCN expression, but
addition of DP, or DP alone, did decreaseMYCN (Figure 3F).
This was also reflected in the immunofluorescence count in
Figure 3B. These results suggest that, after 4 days of FGF2/
BMP2, withdrawal of FGF2 but continuance of BMP allows
SAPs to divert from neuronal differentiation and toward
the chromaffin lineage, whereas after 6 days of FGF2/
BMP2, glucocorticoids are required to achieve this. Thus,
timely withdrawal of the neuronal differentiation factor
FGF2 (Anderson, 1993) is important for chromaffin cell
differentiation.
The concentration of BMP4 influences SAP development
(Reissmann et al., 1996).We confirmed that BMP4 as low as
50 pg/mL activated its downstream signaling pathway in
aTH+ cells by employing an antibody to phosphorylated
SMAD1/5 (Figure S5A). Reducing BMP4 from 500 to
50 pg/mL decreased the proportion of CgB+ cells for both
NCPC-4d andNCPC-6d cells, but NF+ cells were not greatly
altered. The decreased CgB+ cell numbers at NCPC-4d with
low BMP4 was prevented by simultaneous DP (Figure 3C),
confirming the importance of both BMP4 and glucocorti-
coids in chromaffin differentiation (Hodel, 2001; Saxena
et al., 2013). We also investigated glucocorticoid concen-
tration by qPCR for aTH, PNMT, DbH, SOX10, ASCL1,
and HAND2, comparing 10 and 50 mM dexamethasone.
This increase in dexamethasone did not significantly alter
aTH and PNMT expression, whereas HAND2 was strongly
increased and ASCL1 and SOX10 were reduced (Figure 3E).
To investigate the efficiency of differentiation, we fixed
and permeabilized cells after 6 days of chromaffin differen-
tiation of NCPC-4d cells, and stained themwith antibodies
to aTH,CgB, and PNMT. FACS showed that BMP4 alone up-
regulated the percentage of cells expressing aTH, CgB, and
PNMT, with no significant difference in DP and DPBMP4
as we have already shown with the immunofluorescent
counts (Figures 4A, 3B, 3C, and S3). In vivo, aTH+ adrenal
chromaffin cells are both PNMT+ and PNMT (Huber,
2006). In our case, about 30%–40% of aTH+ cells were
PNMT+ (Figure 4A).
Sub-populations from rodent and bovine adrenal chro-
maffin cells proliferate, unlike human chromaffin cells
(Sicard et al., 2007; Tischler and Riseberg, 1993). To investi-
gate proliferation, we immunostained the 9-day BMP4DP-
treated human cells with Ki67 antibody. Ki67 staining was
confined to weakly stained aTH+/CgB+ cells, so prolifera-
tion ability in the human chromaffin-like cells at this stage
is likely to be minimal (Figure S5B).
Figure 3. Human NCPCs/SAPs Differentiate into Chromaffin-like Cells In Vitro
(A) Immunofluorescence of H9 NCPCs/SAPs differentiated with BMP4, showing co-expression of SAP marker, aTH, chromaffin marker,
PNMT, and storage vesicle marker, CgB. Scale bar, 5 mm.
(B and C) Immunofluorescence count of differentiation of NCPC-4d and NCPC-6d cells with 6 days high or low BMP4 stained for aTH,
NF-200kDa, and CgB (see Figures 1A and S1B). Longer initial FGF2/BMP2 exposure resulted in a higher proportion of neuronal (NF+) and a
lower proportion of CgB+ SAP cells. DAPI stain was used to assess the total number of cells. N = 8 independent experiments.
(D and E) qPCR analysis of NCPC-4d and NCPC-6d cells differentiated with BMP4 and/or DP for 6 days. BMP-4 and corticosteroids increase
chromaffin marker PNMT as well as SA markers. N = 4 independent experiments.
(F and G) qPCR analysis of neuronal markers RET and MYCN of NCPC-4d and NCPC-6d cells with BMP4 and/or DP for 6 days. Inclusion of
corticosteroids associated with lower neuronal marker expression. N = 4 independent experiments.
Error bars represent mean ± SEM. ns, not significant, *p > 0.05, **p > 0.01, ***p > 0.001, ****p > 0.0001.
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We hypothesized that the NCPCs treated with BMP4
or DP will possess CAs including adrenaline. These cells
were processed for Faglu (Furness et al., 1977), which con-
verts CAs to a fluorescent product. These were co-immu-
nostained for SAP marker CgB and chromaffin marker
PNMT. Most of the cells staining with Faglu co-stained
for PNMT and CgB, consistent with CA synthesis and
storage (Figure 4B). To measure CA directly, we performed
high-performance liquid chromatography (HPLC) on
sonicated cell lysates of chromaffin-like cells differenti-
ated from H9 NCPCs with BMP4 only and with
DPBMP4. HPLC detected both noradrenaline and adrena-
line, with DPBMP4-treated cells showing moderately
higher levels than BMP4-only treated cells (Figure 4C).
The results also showed that lowering the BMP4 concen-
tration from 500 to 50 pg/mL reduced the concentration
of CAs which corresponds with the data in Figures 3B
and 3C.
Sorting for GD2 Expression Enriches for SAP-like Cells
GD2 sorting enriched SAP-like cells in the mouse ESC
model (Saxena et al., 2013). We asked firstly whether
GD2 is expressed in human NCPCs. Then, because NCPC
populations were heterogeneous (Figure 3B), we asked
whether sorting NCPCs for GD2 would improve the selec-
tion for chromaffin-like cells.
Figure 4. Chromaffin-like Cells Differentiated from NCPCs/SAPs Produce CAs
(A) Representative FACS plot of NCPCs differentiated to chromaffin-like cells as analyzed using aTH and PNMT antibodies. The plot suggests
emergence of aTH+/PNMT and aTH+/PNMT+ sub-populations in BMP4-only conditions, while addition of DP reduces the PNMT sub-
population. N = 8 independent experiments; error bars represent mean ± SEM.
(B) Immunofluorescence of H9 NCPC-4d cells differentiated with BMP4 (50 pg/mL) for 9 days with the chromaffin markers, PNMT, CgB, and
Faglu, markers of CA synthesis and storage. Scale bars, 200 and 5 mm.
(C) HPLC analysis of CA content in lysates of NCPC-4d cells differentiated for 9 days with BMP4 (500 pg/mL), BMP4 (50 pg/mL), DPBMP4
(500 pg/mL), and DPBMP4 (50 pg/mL). BMP4 and corticosteroid mimetic have a stimulatory effect on CA levels. N = 3 independent
experiments. Error bars represent mean ± SEM. *p > 0.05, **p > 0.01.
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NCPCs show amaturation of SA (GD2) and pro-neuronal
(B2B1) properties (Figure 5A). NCPC-4d cells showed
GD2 expression in about 40% of p75NTR+ cells, but, by
6 days, GD2 was expressed by all p75NTR+ cells. The
p75NTR+/GD2+ and p75NTR+/GD2 NCPC sub-popula-
tions expressed NC markers SOX10, TFAP2a, and ASCL1
by immunostaining, and, for the latter two, labeling
was more intense in the p75NTR+/GD2+ sub-population
(Figure 5C). Comparison by qPCR showed a trend for
GD2-associated upregulation of all NC and SAP genes
without attaining significance for all markers (Figure 6A).
We differentiated the GD2– and GD2+ cells using DP
treatment for 6 days and analyzed them by immunofluo-
rescence with SA (aTH), chromaffin (PNMT), and neuronal
markers (PRPH) (Saxena et al., 2013). Cells derived from
GD2+ precursors showed relatively higher level and pro-
portion of expression (Figure 6B), which paralleled results
using mouse cells (Saxena et al., 2013). We also analyzed
the differentiated cells by qPCR normalized to levels in
NCPC-4d cells. GD2+ cells when differentiated with DP
showed greater upregulation of aTH, PNMT, and DbH
compared with GD2-cells, and this increased between 6
and 9 days differentiation (Figure 6C). We conclude that
sorting for GD2 expression after NCPC induction is a useful
means of increasing SA and chromaffin cell differentiation
in the subsequent stage of differentiation.
Similarities andDifferenceswithDifferent Pluripotent
Cell Lines
Similar trends in NCPC generation were seen in H9 and
HES3 hESC- and 007 iPSC-derived cells (Figures 1B, 5B,
and S2). Upregulation of CA synthesis enzyme genes aTH
and PNMTwas shownwith qPCR inHES3- and 007-derived
NCPC-4d cells exposed to BMP4 and DPBMP4 although,
Figure 5. Expression of GD2 and B2B1 in NCPC/SAP Lineages and GD2 Selection
(A) FACS analysis of p75NTR+ H9 NCPC-4d and NCPC-6d cells with GD2 (SAP lineages) and B2B1 (neuroblast lineage) shows increase in SA
and neuronal differentiation. Each representative of ten independent experiments.
(B) Immunofluorescence of NCPC-4d cells sorted as p75NTR+/GD2+ and p75NTR+/GD2, and labeled with NCPC markers SOX10 and
TFAP2a, and SAP marker ASCL1, the latter being enriched by GD2 selection. Scale bar: 50 mm.
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Figure 6. FACS for GD2 Enriches SAP-like Cells
(A) qPCR analysis of SA genes in p75NTR+/GD2+, p75NTR+/GD2 H9 NCPC-4d, and NCPC-6d cells. Expressions were normalized to that of
hESCs. ND, not detectable at <35 cycles. N = 3 (4d) and N = 3 (6d) independent experiments.
(legend continued on next page)
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compared with H9 cells, DbH was relatively more strongly
expressed by HES3 cells and was not upregulated in 007
iPSCs (Figures 3D and S6A). There was a reduction in RET
mRNA expression with BMP4 and DPBMP4 in 007 iPSC-
and HES3 hESC-derived chromaffin-like cells, relative to
NCPC-4d, whereas H9-derived cells showed amoderate up-
regulation, especially with BMP4 (Figures 3F and S6A). For
mRNA expression of pro-neuronal MYCN from NCPC-4d
cells treated with BMP4 or DPBMP4, 007 iPSC-derived cells
showed a reduction similar to that in H9 cells, but HES3-
derived cells displayed an upregulation of MYCN with
BMP4 (Figures 3G and S6A). HES3-hESCs were differenti-
ated to NCPCs, and the expression of GD2 (SA lineage
marker) and B2B1 (pro-neuronal marker) were analyzed
for p75NTR+ cells by FACS. Similar to H9s, a quarter of
p75NTR+ HES3-derived NCPC-4d cells were GD2+, with
very few co-expressing B2B1. However, after 6 days of
FGF2/BMP2 exposure, a far higher proportion (over 90%
compared with 26% in H9) of p75NTR+ HES3-derived cells
co-expressed GD2 and B2B1 (Figures 5A and S6B).
hESC-Derived NCPCs Migrate In Vivo and
Differentiate into Cells Expressing Chromaffin
Markers
To assess the behavior of hESC-derived NCPCs in vivo, we
differentiated GFP+ ENVY-HES3 cells (Costa et al., 2005)
alongNCPC/SAP lines (Hotta et al., 2009) and transplanted
them next to the ‘‘adrenomedullary’’ neural tube of quail
embryos in ovo and incubated the embryos for 4–5 days
(N = 9; Figure 7A). Confocal analysis of cryosections
showed that human NCPC neurosphere cells migrated
away from the implant and differentiated into aTH+ and
PNMT+ cells. The human GFP+ cells had in general
migrated ventral to the vertebral cartilage where sympa-
thetic tissues occur. Frequently aTH+ human cells were
associated with quail aTH+ cells. Other cells were GFP+
but TH, or PNMT (Figures 7B and S7). This is expected
since the hESC-derived NCPCs include SAP and NC-like
cells.
We also transplanted NCPCs derived from H9 hESCs to
the excised ‘‘adrenomedullary’’ level of E2 quail embryos,
and grew these as organ cultures for 3–4 days (N = 9; Fig-
ure 7A). Transplanted human cells in the quail tissue
were identified in whole mounts with anti-human nuclear
antigen (HNA); these co-expressed aTH and CgB and were
surrounded by aTH- and CgB-expressing HNA-negative
quail cells (Figure 7C).
To achieve extended time and greater growth, we used
the same organ culture format as CAM grafts (N = 24; Fig-
ure 7A) (Zhang et al., 2010). CAM graft cryosections could
not be defined by conventional anatomical planes, but sec-
tions which had structures resembling renal tubules were
immunostained. Human cells identified with mouse anti-
human mitochondria antibody were found adjacent to
tubular tissue in the CAM sections (Figure 7D), showed
immunoreactivity for aTH and PNMT, and were often asso-
ciated with quail aTH+ cells.
DISCUSSION
There are previous reports on differentiation of NCPCs and
SAP-like cells fromhuman pluripotent cells (Denham et al.,
2015; Lee et al., 2010) and differentiation of sympathetic
neurons (Oh et al., 2016), but the directed differentiation
of human pluripotent cells to chromaffin-like cells has
not yet been described. Previous reports have outlined
the isolation, culturing, and characterization of human
and bovine adrenal chromaffin cells (Santana et al.,
2012). Here, starting from human pluripotent cells, we
show the temporal increment in numerous SAP-like cell
markers in NCPCs in relation to duration of exposure to
BMP2/FGF2, as shown in mouse and human ESC-derived
SAPs (Oh et al., 2016; Saxena et al., 2013). Our results sug-
gest that the NCPC population at this stage is heteroge-
neous with both NC- and SAP-like cells. We also showed
the utility of sorting for the gangliosideGD2 to concentrate
on the SAP moiety. We also analyzed positional identity
based on the HOX gene expression.
These NCPCs/SAPs could be differentiated in vitro such
that SA and chromaffin markers (CgB, SA1, PNMT, and
adrenaline) were enhanced and sympathetic neuronal
markers (B2B1, MYCN, and RET) reduced. Culture condi-
tions were modeled on those that have been shown to
play an important role in development, in mouse ESCs dif-
ferentiation in vitro, and in human chromaffin cell culture
(Huber et al., 2008; Santana et al., 2012; Saxena et al.,
2013). Our results emphasize the combined importance
of continued BMP signaling to increase chromaffin differ-
entiation and curtailment of FGF2 to reduce sympathetic
(B) NCPC-4d p75NTR+/GD2+ and p75NTR+/GD2 cells after 6 days differentiation in DP express SA (aTH), chromaffin (PNMT), and
neuronal (PRPH) markers. Scale bar, 5 mm. After DP differentiation, PNMT and PRPH are extensively co-expressed, and proportions of these
cells are both increased in the GD2+ population, and all aTH+/GD2+ cells expressed PNMT. DAPI was used to count the total cells. N = 4
independent experiments.
(C) qPCR analysis of NCPC-4d p75NTR+/GD2+ cells differentiated with DP for 6 and 9 days. GD2 preselection augments PNMT expression as
well as other SAP genes. ND, not detectable, N = 4 independent experiments.
Error bars represent mean ± SEM. ns, not significant, *p > 0.05, **p > 0.01, ***p > 0.001, ****p > 0.0001.
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neuron differentiation, the chromaffin lineage choice be-
ing augmented by corticosteroid mimetics.
The NCPC/SAP differentiation method was robust in
that cells expressing p75NTR and HNK-1 were at high pro-
portion in three pluripotent cell lines (H9, HES3 hESCs,
and 007 iPSCs), with H9 hESCs and 007 iPSC at higher pro-
portion than HES3 hESCs. More cells expressed chromaffin
markers in H9- and 007 iPSC-derived cells than in HES3-
derived cells, but the latter showed a bias toward expression
of neuronalmarkers (MYCN, B2B1). There have been previ-
ous reports on differences in differentiation between hESC
lines (Osafune et al., 2008).
Human NCPCs transplanted in vivo into the quail ex-
hibited SAP properties by migrating and differentiating
into cells expressing SA (aTH and CgB) and chromaffin
cell markers (PNMT). Typically, these human cells were
associated with quail cells of the same lineage. This con-
firms the post-transplantation survival, integration, and
differentiation ability of the human NCPCs in situ.
In conclusion, these human chromaffin-like cells derived
from pluripotent cells have the potential for investigating
differentiation of human chromaffin cells, for modeling
specific diseases such as pheochromocytoma, for cell




All experiments were performedwith the approval of theMurdoch
Children’s Research Institute Animal Ethics Committee AEC650
and AEC677 and Institutional Biosafety Committee 226–2015
PC2. Human Stem Cell studies were performed with approval
from the University of Melbourne Human Ethics, ID 1545384
and 0605017.
NCPC Induction
hESCs (H9 [WiCell], HES3 andHES3-ENVY [ESI International]) and
hiPSC (007 iPSC) were cultured to 80%–90% confluence and har-
vested using 0.5 mM EDTA in CMF-PBS for 4–6 min. The buffer
was gently removed and 2mL of medium per 35 cm2 tissue culture
dish was gently added to harvest the cells, which were counted
using a hemocytometer. Cells were seeded at 10,000 per cm2 into
laminin-coated (10 mg/mL in PBS, 1 hr; Life Technologies) orga-
noid culture dishes with TESR-E8 complete medium (STEMCELL
Technologies) supplemented with 10 mM Y-27632 (Sigma-Aldrich)
and cultured at 37C and 5% CO2 in a humidified incubator over-
night; this is recorded as day 0. On day 1, themediumwas changed
to N2B27 medium (Denham et al., 2015) with 3 mM CHIR 99021
and 10 mM SB431542 (both Tocris) and cultured for 5 days.
Medium was replaced on the day 3 after CHIR-SB induction. On
day 5, the cells were termed caudal neural progenitors (CNPs) as
they had a positional identity caudal to the forebrain (Denham
et al., 2015).
CNPs were harvested using EDTA-CMF-PBS for 4–6 min and
centrifuged at 200 3 g for 3 min. The pellet was resuspended in
Neurobasal Medium (Denham et al., 2015) supplemented with
10 ng/mL BMP2 and 20 ng/mL FGF2 (both PeproTech), and plated
in 96-well ultra-low attachment plates (In Vitro Technologies), in
which the cells aggregated to form spheres. On day 7, 9, and 11
(i.e., 2, 4, and 6 days with BMP2/FGF2, termed NCPC-2d, NCPC-
4d, and NCPC-6d), neurospheres were harvested and dissociated
using EDTA-CMF-PBS buffer for 4–6 min and spun down. This is
shown in Figure 1A. To assay for NCPCmarkers by immunofluores-
cence, cells were plated for 5–6 hr on an 8-well Nunc Lab-Tek II
Chamber Slide System (Thermo Fisher Scientific) coated with lam-
inin as above. Otherwise, cells were subjected to chromaffin cell
differentiation (Figures 1A and S1B, see below).
For NCPC/vagal NC differentiation, CNP pellets were processed
as above but with BMP2 50 ng/mL and 50 nM retinoic acid and
plated for 6 days (Denham et al., 2015; Fattahi et al., 2016).
Chromaffin Cell Differentiation from NCPCs and
GD2-Sorted Cells
For differentiation of NCPCs and GD2-sorted NC-derived SAP-like
cells toward the chromaffin lineage (see Figure 1B), NCPC-4d and
NCPC-6d neurospheres were harvested, spun down, and incu-
bated in EDTA-CMF-PBS buffer for 4–6 min to achieve single cells.
Then, 3mL of NBMmediumper 96-well plate of neurospheres was
added and centrifuged, and cells were counted before seeding
them for differentiation. For chromaffin cell differentiation, disso-
ciated cells (8,000–10,000 cells per well) were differentiated for
6–9 days in 96-well ultra-low attachment plates in Differentiation
Medium (DM) of DMEM/F12, 13 GlutaMAX, 2% B27, 0.5% BSA,
13 penicillin/streptomycin (Gibco) supplemented with 500 pg/
mL (or 50 pg/mL) recombinant human BMP4 (R&D Systems)
with or without 10 mM (or 50 mM) dexamethasone (Sigma-
Aldrich) and 100 nM PMA (Millipore). Medium was half changed
every 3 days. Cells were analyzed by qPCR (see below) and cells
Figure 7. NCPC/SAP-like Cells Migrate and Differentiate in Embryonic Tissues
(A) Scheme of the transplantation of hESC-derived NCPCs in quail E2 embryos and incubated in vivo or cultured in vitro or grown on CAM.
(B) Immunofluorescence with chromaffin markers, aTH and PNMT, of NCPCs derived from ENVY-HES3 hESCs transplanted for 4 days in QE2
embryo. This frontal-oblique section is further ventral to the section shown in Figure S7. The human aTH+ cells associate with similar
lineage host cells. Scale bars, 50 mm (upper) and 10 mm (lower).
(C) Immunofluorescence with SA markers, aTH and CgB, and human cell-recognizing antibody, anti-human nuclear antigen, of NCPCs
derived from H9 hESCs transplanted into QE2 tissue and cultured in vitro for 4 days. Scale bar, 50 mm.
(D) Immunofluorescence with chromaffin markers, aTH and PNMT, and anti-human mitochondria antibody of NCPCs derived from H9 hESCs
transplanted into QE2 tissue and cultured on CAM for 8 days. Section is through the aTH-expressing tissue at the margin of mesonephric
kidney tissue (arrow). Scale bar, 50 mm.
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for immunofluorescence analysis (see below) were transferred
directly from the 96-well plate into 12-well chamber slides with
removable microscopy glass slides (ibidi, Germany) coated with
human plasma fibronectin (EMD Millipore, 10 mg/mL in CMF-
PBS for 1 hr at room temperature) and cultured for 4–5 hr. Cells
from 2 wells of a 96-well plate were plated in one well of the
12-well slide.
For chromaffin cell differentiation of GD2 FACS-sorted cells, cells
were dissociated as above and processed for FACS by antibody
staining. FACS-sorted cells, p75+/GD2+ only, and p75+/GD2,
were differentiated for 6 days in 96-well ultra-low-attachment
plates in DM. Cells were analyzed by qPCR (see below) and immu-
nofluorescence as above.
RNA Extraction and SYBR Green qPCR
Using TRIzol (Invitrogen), total RNA was extracted from cultured
cells and lysate were purified by acid-phenol chloroform and
recovered by isopropanol/ethanol precipitation. Extracted RNA
was digested with DNaseI (Promega), following themanufacturer’s
instructions, to remove residualDNA. cDNAwas synthesized using
the Bioline SensiFAST cDNA Synthesis Kit (BIO-65054). In brief,
30 ng total RNAwas converted into cDNA following the manufac-
turer’s directions. Reactions were performed using cDNA con-
verted from 30 ng of RNA, 50 nM of each primer, and AccuPower
2XGreenStarMasterMix solution (Bioneer, SouthKorea), in a total
volume of 10 mL. Primers for qPCR analysis are listed in Table S1.
For TaqMan Assay analysis, reactions were performed using
cDNA converted from 30 ng of RNA, 13 of TaqMan Probe, and
GoTaq Probe qPCR Master Mix solution (Promega) in a total
volume of 10 mL. All runs were in triplicates and more than 3
(N R 3) independent experiments. b2-Microglobullin (b2M)
housekeeping gene was used for data normalization when the rele-
vant gene was undetectable in the control population. Cultured
hESCs, CNP, NCPC-4d, and NCPC-6d were used as a calibration
standard and relative gene expression changes were calculated
using the 2–[D][D]Cq method.
Immunofluorescence
Cells were fixed with 1% paraformaldehyde (PFA) for 15 min, and
permeabilized and blocked for 30 min with 0.2% Triton X-100
and 3% horse serum in CMF-PBS plus 0.02% (w/v) sodium azide.
The cells were then washed once with CMF-PBS and stained with
primary antibodies against aTH, PRPH, CgB, CgC, NF-200 kDa
(all Abcam), ASCL1, SOX10 (both R&D Systems), PNMT (Thermo
Scientific), and Phospho-Smad1/5 (Ser463/465) (41D10) (Cell
Signaling Technology) diluted in blocking buffer at 4C overnight
(refer to Table S2 for full list of antibodies). For detection, cells
were incubated with fluorochrome-conjugated secondary anti-
bodies for 2–3 hr at room temperature. After counterstaining the
nuclei with 10 ng/mL DAPI (Sigma-Aldrich) and mounting in
20 mg/mL 1,4-diazabicyclo[2.2.2]octane (DABCO) (Sigma-Aldrich)
in glycerol, cells were viewed using a Zeiss LSM 780 confocal
microscope (Oberkochen, Germany). Optical and electronic pa-
rameters were maintained for experiments comparing different
conditions.
For whole-mount staining, tissues were stained as described
(Abu-Bonsrah et al., 2016). In brief, tissues were fixed in 4% PFA
in PBS at 4C overnight then washed in PBS three times. Tissues
were blocked and permeabilized with 3% horse serum and 0.2%
TritonX-100 in PBS/azide for 1 hr. Primary antibodies were applied
in 1% horse serum and 0.1% Triton X in PBS azide and incubated
on a rocker at 4C overnight. Washing with PBS was done for 3 hr,
with changes every 30 min on a rocker at 4C. Secondary anti-
bodies and 500 ng/mL DAPI were applied and incubated for 3 hr
on the rocker at 4C. Tissues were washed with PBS three times
and mounted using DABCO/glycerol mounting medium and
then analyzed by confocal microscopy.
For cryostat sections, fixed tissues (4% PFA, 1 hr) were placed in
30% sucrose in CMF-PBS overnight, embedded in Tissue Tek OCT
Medium in Tissue Tek Cryomoulds (from ProSciTech, Thuringowa,
Australia) and frozen in dry ice-cooled isopentane. Twenty-mm
sections were cut using a Leica CM 1900 cryostat microtome
and collected on Superfrost microscope slides (Biolab Scientific,
Auckland, NZ) coated with poly-L-lysine.
Faglu Fluorescence of CAs
NCPCs were fixed in 4% PFA and 0.5% glutaraldehyde in 0.1 M
phosphate buffer, pH 7.0, for 1–2 hr at room temperature (Furness
et al., 1977) to convert CAs to a fluorescent compound. Cells
were washed thrice in CMF-PBS and permeabilized as described
above for combination with immunostaining. The Faglu signal
was detected using the 488 filter set of the Zeiss LSM 780 confocal
microscope.
Cell Quantification
For immunofluorescence cell counts, Olympus IX70 and confocal
images were selected and analyzed using the Zeiss Image Analyser
and ImageJ (NIH). The total number of DAPI nuclei was used as the
total number of cells in a field. With the DAPI channel and one
other color channel, the cells in a field were counted. The ratio
of the different colors to DAPI was calculated. The number of fields
counted varied from three to ten, and images were blinded among
counters.
Cell Culture
The human neuroblastoma line SK-N-BE(2)C (ECACC nos
95011817) was grown in DMEM supplemented with 10% fetal
bovine serum (FBS) and 13 penicillin/streptomycin (both Life
Technologies, Carlsbad, CA, USA), andmaintained in a humidified
incubator at 37C with 5% CO2. Cells were then harvested
for FACS.
HPLC for CA Detection
Differentiated cells for HPLC were prepared according to a previ-
ously published protocol (Saxena et al., 2013). In brief, 20,000 cells
were homogenized in 250 mL sonication buffer of 0.1 M acetic acid
(Sigma) and 2% EDTA (Gibco). QSonica sonicator (Newtown,
CT, USA) was used to sonicate the cells on ice with 3 bursts (5 s
each) at 50% amplitude, at 25-s intervals. Sonicated lysate was
centrifuged for 5 min at 10,000 rpm and the supernatant was
used to analyze CAs by HPLC with fluorescence detection. The
manual derivatizations were performed as described previously
(van der Hoorn et al., 1989). For the derivatization, 10 mL of 1 M
KOH (to neutralize the acetic acid) was added to 40 mL of
sample, which was followed by 68 mL of solution R1 (potassium
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ferricyanide:acetonitrile containing 10 mM isoprenaline as internal
standard, 1,000:80) and 38 mL of solution R2 (1,2-diphenylethyle-
diamine:bicine, 600:300). Incubation was for 45 min at 37C.
Injection volume was 100 mL.
For chromatography, the column was a 15 cm 3 3.9 mm Waters
Symmetry C18, and the mobile phase was 35% acetonitrile in
50 mM sodium acetate, pH 6.8, and run at 2 mL/min. The run-
time was 60 min for each sample. Detection was by fluorescence
at 350 nm excitation and 480 nm emission. Reference standards
of CAs were obtained from the Department of Anaesthesia and
Pain Management, Royal Melbourne Hospital.
FACS and Analysis
NCPC aggregates were harvested using the EDTA-CMF-PBS buffer
for 4–6 min and centrifuged at 200 3 g for 5 min. The pellet was
then resuspended in 5 mL of NBM medium, and 10 mL was
counted using a hemocytometer. Mouse IgM B2B1 antibody and
rabbit p75NTR antibody (for antibodies, see Table S2) was used
to indirectly label the cells for 30 min on ice. Cells were spun
down and washed with CMF-PBS, and then followed by the
respective secondary antibodies, donkey anti-rabbit (Alexa Fluor
594) and anti-mouse IgM (Alexa Fluor 488) for 30 min in the
dark. The cells were washed with CMF-PBS and also directly
labeled with mouse IgG GD2 antibody (Alexa Fluor 647) for
30 min on ice in the dark. For HNK1 and SA1 analysis, mouse
HNK1 IgM antibody and mouse SA1 IgG antibody were used co-
labeled with rabbit p75NTR antibody as above. Goat anti-mouse
IgG-specific (Alexa Fluor 647) and goat anti-mouse IgM-specific
(Alexa Fluor 488) were used to label the cells since these
distinguish between the IgG and IgM primary antibodies. Mouse
serum and rabbit IgG for isotype staining (1:500, Jackson
ImmunoResearch) was used to gauge the degree of non-specific
binding of antibody. The cells were washed with CMF-PBS, pel-
leted, and resuspended in CMF-PBS containing 2% FBS and
strained (40 mm mesh; BD Falcon; Becton Dickinson) and FACS
sorted using the BD FACSAria Fusion Cell Sorter (Becton Dickin-
son, Franklin Lakes, NJ), with separation based on secondary anti-
body, DAPI and live cell staining.
To detect intracellular proteins, cells fixed with 1% PFA were
permeabilized with 0.1% Triton X in 1% horse serum, blocked
with 1% horse serum, and incubated with primary antibodies in
blocking buffer at 4C overnight. After washing with CMF-PBS
and centrifuging, appropriate secondary antibodies were added
for 1 hr and cells were washed and events were acquired with
BD FACS X-20 Fortessa. Data were analyzed using CellQuest
(both from BD Biosciences) and FCS Express 4 Flow (De Novo
Software).
In Vivo Transplantation of hESC-Derived NCPCs
GFP+ ENVY-hESCs were differentiated to NCPCs and transplanted
in ovo between the neural tube and somites at the ‘‘adrenomedul-
lary’’ level of E2 quail embryos (Le Douarin and Teillet, 1974).
Incubation was continued for 4–5 days in a 65% humidified
incubator at 38C. The adrenomedullary regions were excised
and fixed, embedded in Tissue Tek OCT, and frontal cryosections
were collected as above.Human cells were identifiedwith antibody
to GFP.
Organ Culture and CAM Grafts of hESC-Derived
NCPCs
E2 quail embryos were harvested and the adrenomedullary region
was excised. Aggregates of H9 NCPCs were incubated with Calcein
AM cell-permeant dye (1/2000; Thermo Fisher Scientific) for
20–30min tomake the implant visible. After implantation as above,
these were grown in Ham’s F12 supplemented with 10% FCS, 13
pen-strep, and 5% E4 quail embryo extract in a 65% humidified
incubator at 38C. After 24 hr, tissues were checked to confirm
that the implant cells had attached to the tissue. For organ culture,
these were continued in vitro for a further 3–4 days. For extended
time and greater growth the ensemblewas transferred to embryonic
day 8 chick embryo CAM and grown for 8 days (Zhang et al., 2010).
Grafts were fixed, and either whole-mount immunolabeled for
in vitro organ cultures or, for CAM grafts, embedded in Tissue Tek
OCT and cryosectioned. Human cells were identified with mouse
antibodies to HNA and to human mitochondria.
Statistical Analyses
Experiments were independently replicated (i.e., from time zero of
Figure 1) three ormore times (given as N), with technical replicates
(e.g., qPCR) in triplicate. Data were analyzed by using one-way
ANOVA (when analyzing only one variable: gene expression),
two-way ANOVA (when analyzing two variables: time and gene
expression), and unpaired t test with Welch’s correction. Values
were expressed as mean ± SEM. Changes were deemed significant
if the p value was >0.05. Statistical significance is indicated as
follows: *p > 0.05, **p > 0.01, and ***p > 0.001. Graphs were drawn
using GraphPad Prism.
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